Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion type Assertion NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_head.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_provenance.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion evidence source_evidence_literature NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_provenance.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion SIO_000772 22850114 NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_provenance.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion wasDerivedFrom befree-20140225 NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_provenance.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion wasGeneratedBy ECO_0000203 NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_provenance.